Gastrointestinal disorders and of COVID-19: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
To go to the COVID-19 project topics list, click '''[[COVID-19 Project Topics|here]]'''. | |||
{{CMG}} {{AE}} {{F.K}} | {{CMG}} {{AE}} {{F.K}} | ||
Line 6: | Line 8: | ||
==Complications== | ==Complications== | ||
=== | ===Diarrhea=== | ||
=== | ===Nauesa and vomiting=== | ||
=== | |||
=== | ===Abdominal pain=== | ||
===Loss of appetite=== | |||
==References== | ==References== |
Revision as of 14:39, 18 June 2020
To go to the COVID-19 project topics list, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]